Risks & Limitations of Consumer AI Therapy Apps
No consumer AI therapy app is a substitute for a licensed mental health professional. The category has real, documented limitations that any reader should weigh before relying on these tools — especially for moderate-to-severe symptoms, crisis situations, or use by minors. The points below summarise the published evidence and regulatory actions to date.
1. Crisis handling is uneven and not designed for emergencies
Most consumer AI chatbots surface crisis resources (988, Samaritans, Lifeline) when they detect risk language, but the detection is imperfect. Reviews of conversational AI in mental-health contexts have found inconsistent escalation behaviour, occasional dismissive responses, and gaps when users describe risk indirectly. If you or someone you know is in crisis, call 988 in the US, Samaritans 116 123 in the UK/IE, Lifeline 13 11 14 in Australia, or local emergency services — not an app.
2. Companion-style chatbots have faced regulatory scrutiny
Replika has been the subject of FTC complaints alleging deceptive marketing to vulnerable users, and a separate civil lawsuit against Character.AI involves the death by suicide of 14-year-old Sewell Setzer III in 2024, after extended conversations with a Character.AI persona. Companion-style chatbots are not clinical tools, do not have RCT evidence for therapy outcomes, and should not be relied on as a substitute for professional care. We rank Replika low and explicitly do not recommend it as therapy.
3. Effectiveness evidence is strongest for mild-to-moderate symptoms
Wysa, Woebot (now consumer-discontinued), and Youper have published peer-reviewed studies showing meaningful symptom reduction for mild-to-moderate anxiety and depression. Evidence for severe depression, acute PTSD, psychosis, eating disorders, bipolar disorder, and substance-use disorders is much thinner or absent. For these conditions, the right intervention is a licensed clinician — not a chatbot.
4. Use by minors carries additional risks
The FTC has explicitly flagged AI chatbot safety for children and teens as an enforcement priority. Most consumer AI therapy apps require users to be 18+ (or 13+ with parental consent), but age-gating is rarely enforced. We do not recommend any of the apps on this page as a primary mental-health support for under-18s without licensed clinical oversight. Parents should review the privacy policy and crisis-response behaviour before allowing minors to use any of these apps.
5. Data privacy and HIPAA
Most consumer AI therapy apps are not HIPAA-covered entities because they are direct-to-consumer products, not health-care providers. Conversations with these chatbots may be used to train models, sold to third parties, or stored indefinitely. Wysa and a handful of others publish clearer data-handling policies and undergo SOC 2 audits; many competitors do not. Read each app's privacy policy before sharing anything sensitive, and assume your data is not protected the same way it would be in a therapist's office.
6. AI therapy works best as a supplement, not a replacement
The published evidence consistently positions AI therapy chatbots as a useful supplement to professional care — for between-session skill practice, mood tracking, or psychoeducation — not as a replacement. If you are weighing AI therapy as an alternative to seeing a therapist, please read our guide on whether AI therapy is effective and our breakdown of AI therapy versus general-purpose chatbots like ChatGPT before deciding.
This section is informational and does not constitute medical or mental-health advice. If you are in crisis, please call your local emergency services or a crisis hotline. See our editorial guidelines and fact-checking policy for how we evaluate evidence.